Impact of pre-enrolment medication use on clinical outcomes in SUMMIT
J Vestbo, M Dransfield, JA Anderson… - ERJ Open …, 2019 - Eur Respiratory Soc
The impact of prior treatment on results of clinical trials in chronic obstructive pulmonary
disease (COPD) has been debated. We used data from the Study to Understand Mortality …
disease (COPD) has been debated. We used data from the Study to Understand Mortality …
Inhaled corticosteroids and pneumonia mortality in COPD patients
S Suissa - European Respiratory Journal, 2019 - Eur Respiratory Soc
I thank P. Almagro and co-workers for their letter, which provides updated data regarding the
association between inhaled corticosteroids (ICS) and pneumonia mortality in chronic …
association between inhaled corticosteroids (ICS) and pneumonia mortality in chronic …
Prevalence of users of medication targeting obstructive lung disease, the reasons for prescriptions and the use of spirometry in Upernavik Health Center in the period …
H Kallerup, MB Brøndserud - International Journal of Circumpolar …, 2022 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a health problem globally. Smoking is a
risk factor. In Greenland over 50% are smokers. Upernavik Healthcare Center serves the …
risk factor. In Greenland over 50% are smokers. Upernavik Healthcare Center serves the …
Le medicament du mois Trimbow (R) ou triple association bronchodilatatrice et anti-inflammatoire en aérosol dans la broncho-pneumopathie chronique obstructive
JL Corhay, O BONHOMME, J GUIOT - Revue Médicale de Liège, 2018 - orbi.uliege.be
Une triple association fixe en solution extrafine comprenant un corticostéroïde inhalé (CSI),
le dipropionate de béclométasone, un β2-agoniste à effet prolongé (LABA), le fumarate de …
le dipropionate de béclométasone, un β2-agoniste à effet prolongé (LABA), le fumarate de …
Novedades en la clasificación, diagnóstico y tratamiento de la EPOC
MMR Álvarez, D Bron, LCH Márquez, AA Torres… - FMC-Formación Médica …, 2019 - Elsevier
Puntos para una lectura rápida• El infradiagnóstico de la EPOC ha aumentado y se sitúa
actualmente en torno al 81%.• El factor de riesgo principal para desarrollar EPOC es el …
actualmente en torno al 81%.• El factor de riesgo principal para desarrollar EPOC es el …
Eosinophils and the burden of airway disease.
A James - Respirology, 2021 - search.ebscohost.com
Unfortunately, for clinicians, patients with symptoms and spirometry to suggest airflow
obstruction often show a multitude of clinical traits seen in both asthma and chronic …
obstruction often show a multitude of clinical traits seen in both asthma and chronic …
Importance of neutrophils and innate immune competence in the pulmonary response to cigarette smoke exposure
N Milad - 2022 - corpus.ulaval.ca
Résumé Le tabagisme demeure le principal contributeur au développement de plusieurs
maladies, tel que la maladie pulmonaire obstructive chronique (MPOC). La MPOC est …
maladies, tel que la maladie pulmonaire obstructive chronique (MPOC). La MPOC est …
[PDF][PDF] CLINICAL PERSPECTIVES®
P Santus - medmaps.it
Negli ultimi anni gli eosinofili hanno acquisito un crescente interesse nella patogenesi e
come biomarcatore nella BPCO. Il più recente documento GOLD 2020 raccomanda l'utilizzo …
come biomarcatore nella BPCO. Il più recente documento GOLD 2020 raccomanda l'utilizzo …
Inhaled therapy for chronic obstructive pulmonary disease
A Booth - Practice Nursing, 2021 - magonlinelibrary.com
Chronic obstructive pulmonary disease is characterised by progressive symptoms of
productive cough, breathlessness, wheeze and exacerbations. Airway obstruction is …
productive cough, breathlessness, wheeze and exacerbations. Airway obstruction is …